UBS OCONNOR LLC - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAC0. A total of 10 filers reported holding ACORDA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
UBS OCONNOR LLC ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$19,200,000
+0.5%
30,000,0000.0%0.48%
-19.7%
Q2 2023$19,112,118
+1.0%
30,000,0000.0%0.60%
+3.8%
Q1 2023$18,924,498
-99.9%
30,000,0000.0%0.58%
+36.1%
Q3 2022$22,523,000,0000.0%30,000,0000.0%0.43%
+29.4%
Q2 2022$22,523,000,000
-5.4%
30,000,0000.0%0.33%
+44.1%
Q4 2021$23,814,000,000
-0.5%
30,000,0000.0%0.23%
+21.8%
Q3 2021$23,922,000,000
+7.6%
30,000,0000.0%0.19%
-5.1%
Q2 2021$22,228,000,000
+4.3%
30,000,0000.0%0.20%
-35.5%
Q1 2021$21,312,000,00030,000,0000.31%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
CANYON CAPITAL ADVISORS LLC 25,875,000$19,021,0001.51%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 45,283,000$34,415,0000.78%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 52,324,000$38,202,0000.66%
UBS OCONNOR LLC 30,000,000$22,523,000,0000.33%
Soros Fund Management 28,001,000$16,213,0000.29%
Saltoro Capital, LP 1,500,000$1,110,0000.27%
D. E. Shaw & Co., Inc. 14,000,000$10,435,0000.01%
WELLS FARGO & COMPANY/MN 5,018,000$3,814,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ACORDA THERAPEUTICS INC shareholders